glp 1 and glp 2 drugs GLP-1 Medications for Weight Loss: Semaglutide vs Tirzepatide vs Retat – Revolution Health & Wellness Practice Nursing - GLP-1 receptor

Given the observed increased risk of colorectal cancer among patients receiving GLP-1 receptor agonists, clinicians should approach long-term prescribing of these agents with careful consideration, particularly in individuals with additional risk factors for colorectal cancer, such as a family history, obesity, inflammatory bowel disease, or long-standing type 2 diabetes

How Your Genetics Influence GLP-1 Response Not everyone responds to GLP-1 medications the same way

The test is used to assess the risk of fetal chromosomal abnormalities such as Down Syndrome (Trisomy 21), Edwards Syndrome (Trisomy 18), and Neural Tube Defects (NTDs)

For patients who are already self-injecting insulin, the addition of a GLP-1 injection presents no new behavioral challenge and is straightforwardly accepted in clinical practice

has received honoraria or has been a consultant for Angelini, AbbVie, Boehringer Ingelheim, Lundbeck and Otsuka

Dopamine is critical to focus, motivation, and goal-setting